MedPath

evaluation of hysteroscopic effect on endometrial receptivity of the patients in the IVF cycle

Not Applicable
Conditions
Infertility.
Female infertility associated with anovulation,Female infertility of tubal origin,Female infertility of other origin,Female infertility, unspecified,
N97.0,N97.
Registration Number
IRCT2016011022795N2
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
250
Inclusion Criteria

regular mense;age less than 40;BMI=19-30;without any prior hysteroscopy examination or previous IVF or ICSI; with a normal Transvaginal sonography (TVS) (in the day 2-3 same cycle);normal hystrosalpingo graphy (HSG) (between 6to24 mounths) .
Exclusion criteria : recurrent miscamiage (3 or more miscarriage); inter menstrual bleeding; any doubt about uterine cavity abnormality; server male factor request to PESA or TESE; patients with poly cystic ovary syndrome or endometriosis ;hydrosalpinx ;ovarian cyst ; cancellation of the same cycle for any reason

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy rate in two groups. Timepoint: 4 weeks after embryo transfer transvaginal sonography will be done and gestatinal sac will be evaluated. Method of measurement: Find gestational sac on transvaginal sonography.
Secondary Outcome Measures
NameTimeMethod
Chemical pregnancy rate in two group ,abortion , implantation rate in two groups. Timepoint: two weeks after transfer for biochemical pregnancy,4weeks for clinical pregnancy,12 weeks after transfer for abortion,two weeks after transfer for implantation rate. Method of measurement: BHCG for biochemical ,trans vaginal sonography for clinical,physical examination and trans vaginal sonography for abortion ,trans vaginal sonography for implantation.
© Copyright 2025. All Rights Reserved by MedPath